{
    "id": "dbpedia_1874_2",
    "rank": 88,
    "data": {
        "url": "https://cds.ismrm.org/protected/20MProceedings/PDFfiles/E963.html",
        "read_more_link": "",
        "language": "en",
        "title": "",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://cds.ismrm.org/protected/20MProceedings/PDFfiles/images/963/thumbnail/ISMRM2020-000963_Fig1.JPG",
            "https://cds.ismrm.org/protected/20MProceedings/PDFfiles/images/963/thumbnail/ISMRM2020-000963_Fig2.JPG",
            "https://cds.ismrm.org/protected/20MProceedings/PDFfiles/images/963/thumbnail/ISMRM2020-000963_Fig3.JPG"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "References\n\n1. Mueller SG, Schuff N, Weiner MW. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS. NMR Biomed. 2006;19(6):655-68. doi: 10.1002/nbm.1062. PubMed PMID: 16986115; PubMed Central PMCID: PMCPMC1820857.\n\n2. Ashizawa T, Oz G, Paulson HL. Spinocerebellar ataxias: prospects and challenges for therapy development. Nat Rev Neurol. 2018;14(10):590-605. doi: 10.1038/s41582-018-0051-6. PubMed PMID: 30131520; PubMed Central PMCID: PMCPMC6469934.\n\n3. Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR, et al. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med. 2012;4(116):116ra4. doi: 10.1126/scitranslmed.3002693. PubMed PMID: 22238332; PubMed Central PMCID: PMCPMC3720836.\n\n4. Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med. 2012;18(4):624-9. doi: 10.1038/nm.2682. PubMed PMID: 22281806; PubMed Central PMCID: PMCPMC3615719.\n\n5. De Stefano N, Filippi M, Miller D, Pouwels PJ, Rovira A, Gass A, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology. 2007;69(20):1942-52. doi: 10.1212/01.wnl.0000291557.62706.d3. PubMed PMID: 17998486.\n\n6. Weinreb JC, Blume JD, Coakley FV, Wheeler TM, Cormack JB, Sotto CK, et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology. 2009;251(1):122-33. doi: 10.1148/radiol.2511080409. PubMed PMID: 19332850; PubMed Central PMCID: PMCPMC2663583.\n\n7. Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ, et al. Methodological consensus on clinical proton MRS of the brain: Review and recommendations. Magn Reson Med. 2019;82(2):527-50. doi: 10.1002/mrm.27742. PubMed PMID: 30919510.\n\n8. Park YW, Deelchand DK, Joers JM, Hanna B, Berrington A, Gillen JS, et al. AutoVOI: real-time automatic prescription of volume-of-interest for single voxel spectroscopy. Magn Reson Med. 2018;80(5):1787-98. doi: 10.1002/mrm.27203. PubMed PMID: 29624727; PubMed Central PMCID: PMCPMC6107418.\n\n9. Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 Suppl 1:19-32. doi: 10.3109/21678421.2013.778554. PubMed PMID: 23678877; PubMed Central PMCID: PMCPMC4284067.\n\n10. Gunter JL, Bernstein MA, Borowski BJ, Ward CP, Britson PJ, Felmlee JP, et al. Measurement of MRI scanner performance with the ADNI phantom. Med Phys. 2009;36(6):2193-205. doi: 10.1118/1.3116776. PubMed PMID: 19610308; PubMed Central PMCID: PMCPMC2754942.\n\n11. Deelchand DK, Berrington A, Noeske R, Joers JM, Arani A, Gillen J, et al. Across-vendor standardization of semi-LASER for single-voxel MRS at 3T. NMR Biomed. 2019:e4218. doi: 10.1002/nbm.4218. PubMed PMID: 31854045.\n\n12. Joers JM, Deelchand DK, Guo B, Eberly LE, Park YW, Berrington A, et al., editors. Multi-site/Multi-vendor reproducibility of advanced MRS at 3T in a clinical cohort. ISMRM 28th Annual Meeting & Exhibition; 2020; Sydney, Australia.\n\n13. Ratai EM, Zhang Z, Snyder BS, Boxerman JL, Safriel Y, McKinstry RC, et al. Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. Neuro Oncol. 2013;15(7):936-44. doi: 10.1093/neuonc/not044. PubMed PMID: 23645534; PubMed Central PMCID: PMCPMC3688017."
    }
}